Liquidia Corporation is a healthcare company.
Liquidia Corporation (LQDA) is expected to report earnings on Monday, November 2, 2026, after the close. Estimated release time 06:45 ET. Consensus EPS estimate is $0.82.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-12 | FY2026 Q2 | $0.76 | $0.84 | +10.8% | $171.68M |
| 2026-05-11 | FY2026 Q1 | $0.34 | $0.60 | +76.5% | $132.87M |
| 2026-03-05 | FY2025 Q4 | $0.08 | $0.17 | +112.5% | $92.02M |
| 2025-11-03 | FY2025 Q3 | $-0.45 | $-0.04 | +90.9% | $54.34M |
| 2025-08-12 | FY2025 Q2 | $-0.43 | $-0.49 | -14.0% | $8.84M |
| 2025-05-08 | FY2025 Q1 | $-0.42 | $-0.45 | -7.1% | $3.12M |
| 2025-03-19 | FY2024 Q4 | $-0.38 | $-0.45 | -18.4% | $2.92M |
| 2024-11-13 | FY2024 Q3 | $-0.37 | $-0.30 | +18.9% | $4.45M |
LQDA has beaten consensus EPS in 5 of its last 8 reported quarters.
LQDA reported Aug 12. The highlights: EPS of $0.84 — a beat vs the $0.76 estimate (+11%); revenue of $172M — in line with the $168M consensus.
See LQDA on the live calendar →